Long-term survival after alcohol septal ablation for hypertrophic obstructive cardiomyopathy: a comparison with general population
Josef Veselka(Universitat Autònoma de Barcelona), David Zemánek, Pavol Tomašov(Charles University), Jan Krejčí(University Hospital Brno)
Cited by 106
Related Papers
Mavacamten for treatment of symptomatic obstructive hypertrophic cardiomyopathy (EXPLORER-HCM): a randomised, double-blind, placebo-controlled, phase 3 trial
|The Lancet|2020|1.2k
Long‐term health outcome and mortality evaluation after invasive coronary treatment using drug eluting stents with or without the IVUS guidance. Randomized control trial. HOME DES IVUS
|Catheterization and Cardiovascular Interventions|2009|190
A FTO variant and risk of acute coronary syndrome
|Clinica Chimica Acta|2010|65
Parathyroid Hormone and Vitamin D Levels are Independently Associated With Calcific Aortic Stenosis
|Circulation Journal|2008|64